WO2004098599A3 - Proton pump inhibitors for the treatment of lower abdominal disorders - Google Patents
Proton pump inhibitors for the treatment of lower abdominal disorders Download PDFInfo
- Publication number
- WO2004098599A3 WO2004098599A3 PCT/EP2004/050694 EP2004050694W WO2004098599A3 WO 2004098599 A3 WO2004098599 A3 WO 2004098599A3 EP 2004050694 W EP2004050694 W EP 2004050694W WO 2004098599 A3 WO2004098599 A3 WO 2004098599A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- proton pump
- lower abdominal
- pump inhibitors
- abdominal disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004237362A AU2004237362A1 (en) | 2003-05-06 | 2004-05-04 | Proton pump inhibitors for the treatment of lower abdominal disorders |
MXPA05011699A MXPA05011699A (en) | 2003-05-06 | 2004-05-04 | Agents for the treatment of lower abdominal disorders. |
CA002524268A CA2524268A1 (en) | 2003-05-06 | 2004-05-04 | Proton pump inhibitors for the treatment of lower abdominal disorders |
EP04731018A EP1660084A2 (en) | 2003-05-06 | 2004-05-04 | Proton pump inhibitors for the treatment of lower abdominal disorders |
US10/555,055 US20060235053A1 (en) | 2003-05-06 | 2004-05-04 | Agents for the treatment of lower abdominal disorders |
NO20055563A NO20055563L (en) | 2003-05-06 | 2005-11-24 | Means for the treatment of lower abdominal disorders |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03010168 | 2003-05-06 | ||
EP03010168.7 | 2003-05-06 | ||
EP03016362 | 2003-07-19 | ||
EP03016362.0 | 2003-07-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004098599A2 WO2004098599A2 (en) | 2004-11-18 |
WO2004098599A3 true WO2004098599A3 (en) | 2005-02-03 |
Family
ID=33436110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/050694 WO2004098599A2 (en) | 2003-05-06 | 2004-05-04 | Proton pump inhibitors for the treatment of lower abdominal disorders |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060235053A1 (en) |
EP (1) | EP1660084A2 (en) |
AU (1) | AU2004237362A1 (en) |
CA (1) | CA2524268A1 (en) |
MX (1) | MXPA05011699A (en) |
NO (1) | NO20055563L (en) |
WO (1) | WO2004098599A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8679545B2 (en) * | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
CA2635272C (en) | 2006-01-27 | 2016-11-29 | Yale University | Fast acting inhibitor of gastric acid secretion |
US8512761B2 (en) * | 2006-01-27 | 2013-08-20 | Yale University | Fast acting inhibitor of gastric acid secretion |
MX2008015967A (en) * | 2006-06-15 | 2009-01-09 | Novartis Ag | Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury. |
JP2011503073A (en) | 2007-11-13 | 2011-01-27 | メリテイジ ファーマ,インク. | Corticosteroid composition |
US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
US20090143343A1 (en) * | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
AU2013323476A1 (en) * | 2012-09-27 | 2015-07-30 | Claresa LEVETAN | Insulin independence among patients with diabetes utilizing a PPI in combination with an immune tolerance agent |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0272876A2 (en) * | 1986-12-17 | 1988-06-29 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
US5330982A (en) * | 1986-12-17 | 1994-07-19 | Glaxo Group Limited | Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith |
KR940006531B1 (en) * | 1991-08-30 | 1994-07-21 | 주식회사 코오롱 | Process for preparation of pyridine derivatives |
WO2003053221A2 (en) * | 2001-12-19 | 2003-07-03 | Eisai Co. Ltd | Methods using proton pump inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0695123A4 (en) * | 1993-04-27 | 1996-09-11 | Sepracor Inc | Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole |
US6156771A (en) * | 1997-08-28 | 2000-12-05 | Rubin; Walter | Method for alleviation of lower gastrointestinal disorders in a human patient |
DE19843413C1 (en) * | 1998-08-18 | 2000-03-30 | Byk Gulden Lomberg Chem Fab | New salt form of pantoprazole |
-
2004
- 2004-05-04 WO PCT/EP2004/050694 patent/WO2004098599A2/en active Application Filing
- 2004-05-04 AU AU2004237362A patent/AU2004237362A1/en not_active Abandoned
- 2004-05-04 MX MXPA05011699A patent/MXPA05011699A/en unknown
- 2004-05-04 CA CA002524268A patent/CA2524268A1/en not_active Abandoned
- 2004-05-04 US US10/555,055 patent/US20060235053A1/en not_active Abandoned
- 2004-05-04 EP EP04731018A patent/EP1660084A2/en not_active Withdrawn
-
2005
- 2005-11-24 NO NO20055563A patent/NO20055563L/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0272876A2 (en) * | 1986-12-17 | 1988-06-29 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
US5330982A (en) * | 1986-12-17 | 1994-07-19 | Glaxo Group Limited | Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith |
KR940006531B1 (en) * | 1991-08-30 | 1994-07-21 | 주식회사 코오롱 | Process for preparation of pyridine derivatives |
WO2003053221A2 (en) * | 2001-12-19 | 2003-07-03 | Eisai Co. Ltd | Methods using proton pump inhibitors |
Non-Patent Citations (3)
Title |
---|
"Martindale 32nd edition", 1999, PHARMACEUTICAL PRESS, LONDON, XP002257060 * |
DATABASE WPI Section Ch Week 199617, Derwent World Patents Index; Class B03, AN 1996-169761, XP002255908 * |
DAVE B ET AL: "Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea.", DIGESTIVE DISEASES AND SCIENCES. UNITED STATES SEP 1999, vol. 44, no. 9, September 1999 (1999-09-01), pages 1893 - 1898, XP008022645, ISSN: 0163-2116 * |
Also Published As
Publication number | Publication date |
---|---|
CA2524268A1 (en) | 2004-11-18 |
NO20055563L (en) | 2005-11-24 |
EP1660084A2 (en) | 2006-05-31 |
MXPA05011699A (en) | 2006-01-23 |
AU2004237362A1 (en) | 2004-11-18 |
WO2004098599A2 (en) | 2004-11-18 |
US20060235053A1 (en) | 2006-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004078116A3 (en) | P38 inhibitors and methods of use thereof | |
WO2006044825A3 (en) | Mitotic kinesin inhibitors and methods of use thereof | |
WO2010038086A8 (en) | P38 map kinase inhibitors | |
TW200510416A (en) | P38 inhibitors and methods of use thereof | |
WO2005117870A3 (en) | Combination of proton pump inhibitor, buffering agent, and prokinetic agent | |
WO2006003388A8 (en) | Compositions and methods for treating inflammatory disorders | |
WO2006017384A3 (en) | Indazoles useful in treating cardiovascular diseases | |
NO20055563L (en) | Means for the treatment of lower abdominal disorders | |
WO2005044199A3 (en) | Combination of proton pump inhibitor and sleep aid | |
WO2004074243A3 (en) | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands | |
WO2006055871A3 (en) | Treatment for multiple sclerosis | |
ZA200709072B (en) | Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders | |
WO2008011478A3 (en) | Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds | |
TW200716153A (en) | Mitotic kinesin inhibitors and methods of use thereof | |
PL373085A1 (en) | Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers | |
TW200716561A (en) | P38 inhibitors and methods of use thereof | |
WO2003094967A3 (en) | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders | |
WO2006042277A3 (en) | Extended release compositions of proton pump inhibitors | |
WO2003043614A3 (en) | Reversible proton pump inhibitors for the treatment of airway disorders | |
WO2005077018A3 (en) | Methods of treating skin disorders | |
WO2005107464A3 (en) | Compounds and compositions as cathepsin s inhibitors | |
WO2003075926A8 (en) | Use of proton pump inhibitors for the treatment of airway disorders | |
WO2005023253A8 (en) | Use of pde4 inhibitors for the treatment of diabetes mellitus | |
WO2004103291A3 (en) | Extended release compositions of proton pump inhibitor | |
WO2008147763A8 (en) | Mmp inhibitors and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005/08341 Country of ref document: ZA Ref document number: 200508341 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2005/011699 Country of ref document: MX Ref document number: 2524268 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 543699 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006235053 Country of ref document: US Ref document number: 10555055 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004237362 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004731018 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2004237362 Country of ref document: AU Date of ref document: 20040504 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004237362 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004731018 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10555055 Country of ref document: US |